Catalent Pharma Solutions has a new Vice President of Development and Analytical Services.
Sally Langa has joined the drug delivery technology firm from Halo Pharma where she was Vice President, Sales and Marketing.
Langa's career within the pharmaceutical services industry spans almost 30 years and she has held a number of senior positions at Patheon.
In her new role, Langa will be responsible for growing Catalent’s early phase development business for small molecule compounds, including analytical services, formulation development, and micronisation.
Catalent’s Development and Analytical services, located at sites throughout the US and Europe, offer global solutions with specialist handling capabilities for controlled substances, highly potent, cytotoxic, and temperature critical compounds, to handle the most challenging molecules.
